Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.65	64.08	67.21
Graham Fair Price	9.36	31.80	29.08
PEG	-63.17	1.35	3.68
Price/Book	7.08	6.59	6.16
Price/Cash Flow	-48.10	114.66	220.93
Prices/Earnings	-3.25	20.40	21.08
Price/Sales	18.70	23.99	20.21
Price/FCF	-48.10	114.66	220.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.58	0.58	0.56
Operating Margin	21.18	0.33	0.27
ROA	12.99	0.06	0.05
ROE	0.07	0.08	10.68
ROIC	0.06	0.07	12.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.08	-94.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.11	0.13	17.65
EPS QOQ	0.06	0.15	162.72
FCF QOQ	-0.65	1.13	74.02
Revenue QOQ	0.13	-0.07	-46.01
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	50.01	49.83	-0.37
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.09	0.05	-47.54
Quick Ratio	1.94	1.98	2.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.69	23.59	3.95
Cash	8.88	8.71	-1.97
Capex	-0.88	-0.97	-9.65
Free Cash Flow	0.63	1.36	114.48
Revenue	6.91	6.48	-6.22
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.10	2.15	2.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.17	0.13	-24.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating